The landscape of drug/device development is evolving rapidly. Let us find a solution that best fits your needs.
RMBio will be your partner to provide deep technical insights to assess early-stage biotech startups and high-risk investments.
Venture Capital Firms
-
Startup & Technology Evaluation
Comprehensive technical due diligence of biotech and medtech startups
Feasibility assessment of new therapies, devices, and biomaterials
Market viability and competitive positioning analysis
Evaluation of nanomedicine and biotech innovations for commercialization potential
-
Investment & Risk Strategy
Risk assessment for early-stage biotech investments
Prediction of regulatory and clinical hurdles for startups
Evaluation of product-market fit and IP strength
Advising on potential exit strategies (M&A, IPO, licensing deals)
-
Scientific & Business Strategy Support
Guidance on startup funding strategies based on biotech sector trends
Evaluation of R&D pipelines and probability of technical success
Advising VCs on investment diversification in biotech portfolios
